Staidson BIO’s Shaky Stock: High Volatility, Negative P/E, & Future Challenges
Staidson Beijing Biopharmaceuticals: high‑risk biotech with promising products but a steep negative P/E and volatile stock price. Understand the company’s challenges and potential for future turn‑around.
3 minutes to read